Immunotherapy Drug, Avelumab, Boosts Survival With Bladder Cancer

MONDAY, Sept. 21, 2020 — An immunotherapy drug significantly improved survival in patients with the most common type of bladder cancer, according to a new study.
About 550,000 new cases of bladder cancer are diagnosed worldwide each year, making…
Source: Topamax